Active
TERM 2
August 13 2025 · 384 days ago
🏥 Healthcare
Executive Order 14336 directs the establishment and filling of a Strategic Active Pharmaceutical Ingredients Reserve to strengthen domestic pharmaceutical supply chains. The order aims to reduce U.S. dependence on foreign sources for critical drug components and improve resilience against supply disruptions. Americans may see increased availability and potentially lower costs for essential medications through enhanced domestic pharmaceutical production capacity.
Active
TERM 2
May 2025 · 461 days ago
🏥 Healthcare
The Drug Enforcement Administration announced plans to temporarily classify 7-hydroxymitragynine (7-OH) and three related kratom-derived compounds as Schedule I controlled substances, placing them in the same category as heroin and LSD. The action would eliminate legal access to products containing these substances and criminalize possession. The policy affects thousands of Americans who use kratom products for pain management and wellness purposes.
Active
TERM 2
May 2025 · 465 days ago
🏥 Healthcare
Health Secretary Robert F. Kennedy Jr. restructured the Advisory Committee on Immunization Practices (ACIP), a key federal vaccine policy body. Senate Democrats launched an investigation into the legal and public health consequences of the panel changes. The action affects vaccine approval processes and guidance affecting millions of Americans.
Active
TERM 2
May 12 2025 · 477 days ago
🏥 Healthcare
President Trump signed Executive Order 14297 to implement Most-Favored-Nation (MFN) pricing for prescription drugs, requiring Medicare to pay no more than the lowest price paid in other developed nations. The order aims to reduce drug costs for American patients and Medicare spending by allowing the government to negotiate lower pharmaceutical prices based on international benchmarks.
Active
TERM 2
May 5, 2025 · 484 days ago
🏥 Healthcare
Executive Order 14293 signed on May 5, 2025, removes regulatory barriers to increase domestic production of critical medicines in the United States. The order streamlines FDA approval processes and reduces compliance requirements for pharmaceutical manufacturers. This aims to reduce American dependence on foreign drug sources and lower medication costs for consumers.
Active
TERM 2
May 2025 · 487 days ago
🏥 Healthcare
The Trump administration ousted FDA acting drug chief Dr. Tracy Beth Høeg, acting vaccines chief Katherine Szarama, and chief of staff Jim Traficant in a major leadership shake-up. The agency now lacks a permanent commissioner and stable leadership during critical drug approval and vaccine oversight functions. The departure of experienced regulators weakens FDA capacity to evaluate drug safety and vaccine efficacy during a period of potential regulatory rollback.
Active
TERM 2
May 1 2025 · 488 days ago
🏥 Healthcare
The Trump administration's budget law mandates work requirements for Medicaid beneficiaries, with Nebraska implementing the policy on May 1 and most states required to follow by January. The requirement forces many low-income Americans to prove employment to maintain health coverage, directly affecting millions of vulnerable populations who may struggle to meet work documentation standards.
Active
TERM 2
April 15 2025 · 504 days ago
🏥 Healthcare
President Trump signed Executive Order 14273 on April 15, 2025, implementing measures aimed at lowering prescription drug prices for American consumers. The order directs federal agencies to reduce pharmaceutical costs through regulatory reform and market mechanisms. This action is intended to decrease out-of-pocket medication expenses for Medicare, Medicaid, and privately insured Americans.
Active
TERM 2
April 2025 · 512 days ago
🏥 Healthcare
The Department of Health and Human Services withdrew its proposed amendment to the charter of a key vaccine advisory committee that would have loosened eligibility requirements for panel members. The withdrawal, citing administrative errors, halts efforts to restructure the influential committee's membership criteria. The action affects the composition and independence of the advisory body that shapes national vaccination policy.
Active
TERM 2
April 2025 · 518 days ago
🏥 Healthcare
The Trump administration eliminated over $800 million in federal grants from the Department of Justice's Office of Justice Programs designated for community violence intervention initiatives in April 2025. These programs have proven more effective at reducing homicides than arrest-focused approaches. The cuts risk reversing recent dramatic declines in US homicide rates and disproportionately harm communities already experiencing high rates of violent crime.